Flying with Wegovy or Ozempic: TSA, Customs, and Cold Chain

Flying internationally with a GLP-1 pen is mostly an administrative problem, not a medical one. The TSA explicitly permits injectable medications and the cooling supplies needed to keep them cold in carry-on baggage^[1]. The FDA storage section of each drug's prescribing information (Wegovy^[2], Ozempic^[3], Zepbound^[4], Mounjaro^[5]) allows the pen to be kept at room temperature (up to 86°F / 30°C) for a finite window once it leaves the refrigerator. International customs is the bigger variable: most countries allow up to a 90-day personal supply of a prescription injectable for personal use, but Japan requires a Yakkan Shoumei certificate for certain quantities^[9], the UK and Schengen-area countries want the original pharmacy label plus a physician's letter^[10][12], and Australia caps personal-supply imports at three months^[11]. This article walks through the verified rules for the five travel scenarios that come up most: TSA security in the U.S., long-haul flights with the pen in carry-on, time-zone dose shifts, customs declarations in Schengen / UK / Japan / Australia, and what to do if a pen is lost, damaged, or warms up beyond label limits abroad. It also covers cruise-ship logistics, hotel-room refrigeration beyond the 28-day room-temperature window, and the extra documentation compounded-vial-and-syringe users need that branded-pen users don't.

The honest summary

• TSA carry-on is unambiguously allowed. The TSA Disability and Medical Conditions policy explicitly permits injectable medications, syringes, ice packs, gel packs, and freezer packs (in any state — frozen, partially frozen, or liquid) in carry-on baggage at any quantity needed for the trip^[1]. The 3.4-oz liquid rule does not apply to prescription medication.
• Carry-on, not checked. Checked-baggage cargo holds can drop below freezing on long flights and routinely exceed 86°F on the tarmac in summer. The pen storage range on the FDA label is 36-46°F refrigerated or up to 86°F (30°C) at room temperature^[2][4]. Cargo hold is outside both.
• 6-12-hour flights are fine in carry-on. Cabin temperature is regulated to roughly 70-75°F. An unrefrigerated pen in a regular carry-on bag stays well inside the 86°F label limit for a typical international flight. For flights beyond ~12 hours, a small FRIO or insulated cooler bag with a gel pack adds margin.
• Most countries allow a 90-day personal supply of prescription medication for personal use without prior authorization, provided it is in the original labeled packaging^[10][11][12]. Japan is the exception that catches Americans out — quantities above a one-month supply (or any injectable in some interpretations) require a Yakkan Shoumei import certificate applied for 14-30 days before travel^[9].
• Once-weekly dosing forgives time-zone shifts. Wegovy, Ozempic, Zepbound, and Mounjaro are once-weekly injections. The FDA prescribing information for all four drugs permits a dose to be taken up to 5 days early or up to 2 days late (semaglutide) or up to 4 days early or late (tirzepatide) without correction. The half-life is roughly a week, which is why the dosing schedule is so forgiving.
• Compounded-vial-and-syringe users need extra documentation. Loose insulin syringes and a labeled vial without a pharmacy-applied retail-prescription sticker trigger more customs questions than a branded pen. A physician letter on letterhead specifying the medication, dose, indication, and quantity is functionally required for compounded users.
• Cruises are stocked for cardiac and diabetes emergencies, not GLP-1 obesity treatment. Cruise medical centers do not stock semaglutide or tirzepatide. Bring the entire planned supply for the cruise plus a one-pen buffer.

TSA security: the rules in writing

The TSA “What Can I Bring?” medication page is the primary source^[1]. The relevant rules for a GLP-1 user flying out of any U.S. airport:

• Prescription and OTC medications are allowed in any quantity in carry-on baggage. The 3.4-oz / 100-mL liquid rule does not apply to medication. This covers the pen itself, any backup pens, and any compounded vials.
• Ice packs, gel packs, and freezer packs are allowed when accompanying medication that needs to be kept cold. They can be partially frozen, slushy, or even fully melted — TSA does not require the cooling material to be in any specific state. They prefer the pack be fully frozen for clearer X-ray imaging, but partially frozen or liquid is still permitted under the medication exemption.
• Declare the medication to the officer at the start of screening. Saying “I have prescription medication that needs to stay cold” routes you through the standard medical-medication screening lane and avoids the pack being treated as a regular liquid. You do not need to remove the pens from the bag unless asked.
• A prescription is not required at TSA, but the original pharmacy label is strongly recommended. The label on the box (with your name, the prescriber, the dispensing pharmacy, and the drug name) is the document that most international customs officers will want to see later in the trip. Keep the pen in the labeled retail box for the entire trip.

Cold-chain logistics on long-haul flights

The FDA-approved storage range for an unopened pen is 36-46°F (2-8°C) refrigerated, with room-temperature exposure permitted up to 86°F (30°C) for a finite window once the pen leaves the refrigerator. The specific window varies by product:

• Wegovy (Novo Nordisk; DailyMed prescribing information^[2]): unopened pens may be stored at room temperature (up to 86°F / 30°C) for up to 28 days.
• Ozempic (Novo Nordisk; DailyMed prescribing information^[3]): after first use, the pen may be stored at room temperature or refrigerated and used for up to 56 days; before first use, refrigerated storage is required.
• Zepbound and Mounjaro (Eli Lilly; DailyMed prescribing information^[4][5]): unrefrigerated room-temperature storage permitted up to 86°F (30°C) for up to 21 days. Past 21 days unrefrigerated, the label directs disposal.

Cabin air on a commercial flight is regulated to roughly 70-75°F (21-24°C), well inside the label range. A pen in a regular carry-on bag for a 6-12-hour international flight needs no active cooling. For very long-haul flights, layovers in hot climates, or any scenario where the bag may sit on a sun-exposed gate-area floor, a FRIO insulated case (evaporative cooling, no ice required) or a MedAngel-style temperature-monitored cooler bag with a frozen gel pack adds margin. The frozen gel pack is TSA-allowed under the medication exemption^[1].

The single most common mistake. Travelers sometimes put the pen in checked baggage to avoid “the TSA conversation.” Cargo holds are unpressurized and unheated below the deck. Documented cargo-hold temperatures on long-haul flights span roughly −10°F to over 100°F depending on routing, season, and aircraft type. Freezing denatures the peptide. Keep the pen in carry-on, always.

Time-zone dose timing

The half-life of semaglutide is approximately one week. The half-life of tirzepatide is approximately five days. That is why the dosing schedule is so forgiving: shifting an injection day by 24-48 hours produces a negligible change in steady-state plasma concentration. The FDA prescribing information reflects this. Semaglutide labels permit a missed dose to be taken up to 5 days late; if more than 5 days have passed, skip and resume the regular weekly schedule. Tirzepatide labels permit a missed dose to be taken up to 4 days late.

Practical guidance for crossing time zones:

• Short trips (under 2 weeks, any direction). Keep your home injection day and time. Take the dose on the same calendar day as usual. If your usual injection is Sunday morning at home in Los Angeles, take it Sunday morning local time wherever you are. The slight clock-time shift does not matter.
• Long trips with a permanent time-zone shift (sabbatical, expat assignment, multi-month travel). Pick a new injection day at the destination and stick with it. The transition is one weekly cycle — take your home dose the day before you leave, take the next dose 7 days later on whatever local day that lands on, and that becomes the new schedule.
• Never double-dose. If you miscalculate and arrive at the next injection day having missed the previous one by more than the label window, skip the missed dose and resume the regular weekly schedule. Doubling the dose to “catch up” doubles the risk of nausea, vomiting, and gastric stasis without any clinical benefit (Wharton 2022 GI side-effect management^[8]).

International customs by region

Customs rules for prescription medication are set by the destination country, not the U.S. The most common framework is: a 90-day personal supply of a prescription injectable for personal use is permitted, in original labeled packaging, with the original prescription or a physician's letter on request. The four jurisdictions American travelers ask about most:

Schengen Area (most of continental Europe)

Personal-use medication is generally permitted across Schengen borders for the quantity needed for the duration of the stay^[12]. For controlled substances (which GLP-1s are not), a Schengen Article 75 certificate is required; GLP-1s do not need this. Practical documentation to carry: original labeled retail box, a copy of the prescription, and a brief physician's letter on letterhead stating the medication, dose, indication (“chronic weight management” or “type 2 diabetes” as appropriate), and the duration of the trip. The letter is rarely requested but solves any confusion in seconds when it is.

United Kingdom

The UK Home Office permits travelers to bring a personal supply of prescription medication for the duration of stay^[10]. For trips up to three months, the original labeled pharmacy packaging is sufficient. For longer stays or larger quantities, a physician's letter is advised. Controlled drugs require additional documentation; GLP-1s do not appear on the UK controlled-drug schedules.

Japan

Japan is the jurisdiction that most often catches American travelers off guard. The Ministry of Health, Labour and Welfare requires a Yakkan Shoumei (medication import certificate) for quantities of prescription medication above the personal-use threshold^[9]. The thresholds: prescription medication for up to one month of personal use is generally allowed without Yakkan Shoumei; quantities above one month, or injectables of any quantity in some interpretations, require the certificate. The application is filed with the Regional Bureau of Health and Welfare at the airport of arrival and takes 14-30 days. For a 90-day trip carrying 13 weekly Wegovy pens, the certificate is unambiguously required. The certificate is free but cannot be obtained at the border — travelers without it have had medication confiscated at Narita and Haneda. Allow 30 days lead time and bring the printed certificate.

Australia

The Traveller's Exemption under the Therapeutic Goods Administration permits travelers to bring a 3-month personal supply of prescription medication into Australia for personal use^[11]. The medication must be in the original labeled packaging or accompanied by a prescription / physician's letter, and the traveler must be the patient named on the prescription. Quantities above 3 months require a TGA personal-import permit applied for in advance.

Other destinations

Most other developed countries follow a similar 90-day personal-supply framework for non-controlled prescription injectables. Notable strict jurisdictions: Singapore (declare all injectables at customs; permit may be required for quantities above one month), the UAE (a prescription is required; some medications require Ministry of Health approval in advance), and South Korea (personal-supply quantities generally allowed but a prescription is required at customs request). Always check the destination country's embassy or customs site within 30 days of travel; rules change.

Hotel refrigeration and stays beyond 28 days

Most hotel mini-bar refrigerators run 36-46°F — exactly the FDA-label range. For stays longer than the room-temperature window (28 days unrefrigerated for Wegovy^[2], 21 days for Zepbound and Mounjaro^[4][5]), a refrigerator is required to extend pen viability. Practical notes:

• Mini-bar fridges are usually fine, but verify. A cheap fridge thermometer ($5 at any drugstore) confirms the temperature within a few hours of check-in. If the fridge is running too cold (below 36°F), move the pens away from the freezer compartment or to a less-cold shelf.
• Don't freeze. A pen that has frozen at any point should be discarded. The peptide denatures with freezing and cannot be rescued by thawing. If the mini-bar is a single-compartment freezer-with-shelf design, that is not a safe pen-storage location.
• Travel cooler bags for trips beyond hotel options. For multi-week camping, expedition, or remote travel where hotel-room refrigeration is not available, an active cooler (12V plug-in mini-fridge for car travel, or a battery-powered medical cooler like the MedAngel ONE or DISON DI-12 for backcountry) maintains the 2-8°C range. Passive evaporative-cooling cases (FRIO) extend the room-temperature window in hot climates but do not refrigerate.

Cruise ship considerations

Cruise medical centers stock for the predictable in-flight emergencies: cardiac events, gastroenteritis outbreaks, diabetic ketoacidosis, motion sickness, common infections. They do not stock GLP-1 receptor agonists for obesity treatment. If a pen is lost, dropped overboard, or damaged at sea, the cruise medical officer cannot replace it; the next available pharmacy is at the next port, which may be 2-5 days away.

Practical cruise guidance:

• Bring the cruise supply plus one buffer pen. For a 14-day cruise with weekly dosing, that is 2 pens used plus 1 buffer = 3 pens packed.
• Use the in-cabin mini-fridge. Verify temperature with a $5 thermometer in the first few hours. Most cruise mini-bars run 36-46°F.
• Carry a physician letter listing the medication. Some cruise lines (and some port-of-call customs offices) ask for documentation when boarding with injectables and syringes.
• Compounded vials need extra packaging attention. Loose syringes and a vial without a retail pharmacy label trigger more questions at both cruise embarkation and port-of-call customs than a branded pen.

Lost, stolen, or damaged pen abroad

Replacing a GLP-1 pen abroad is straightforward in prescription-friendly jurisdictions and difficult in restrictive ones. The general pattern:

• EU / UK / Australia / Canada / most of Latin America: walk into a major-chain pharmacy with the original prescription or a physician's letter and ask for a local prescription transfer. Many pharmacies in tourist areas have streamlined processes for travelers. Cost is typically the local cash-pay price (often 40-70% lower than U.S. retail for branded semaglutide and tirzepatide).
• Japan: requires a Japanese-licensed physician consultation before any prescription is issued. Major hospitals in Tokyo and Osaka have international-traveler clinics. Expect a same-day to 2-day turnaround.
• Restrictive jurisdictions (Singapore, UAE, parts of Southeast Asia): assume replacement is not possible without flying out. The buffer-pen strategy is the intervention.
• Telehealth as a fallback. Some U.S. telehealth providers can ship a replacement pen to a U.S. address if a family member can then international-ship it; this is slow (1-2 weeks) and the international shipping of refrigerated medication is not always reliable.

Compounded vials and insulin syringes: the extra documentation problem

Branded-pen users (Wegovy, Ozempic, Zepbound, Mounjaro) travel on the strength of the pre-printed pharmacy label on the retail box. Compounded semaglutide and tirzepatide users do not have that label. The vial typically has a generic compounding-pharmacy sticker; the syringes are separately packaged loose insulin syringes. International customs officers see this and pattern- match to either insulin diabetes care (acceptable) or recreational-injection drug-use (problematic) depending on documentation.

Required extras for compounded users:

• Physician letter on letterhead. Should specify: patient name, medication (“compounded semaglutide injection” or “compounded tirzepatide injection”), dose, indication, quantity packed for the trip, prescribing physician name and license number, and a phone number reachable in the U.S. time zone.
• Copy of the original telehealth-platform prescription if the platform makes one downloadable.
• Original compounding-pharmacy receipt showing the medication, dose, and patient name.
• Sealed unopened syringe packs in their retail packaging. Loose syringes in a pill organizer are the single fastest way to escalate a customs conversation.

Documentation checklist for international travel

• Pen / vial in original labeled retail or pharmacy packaging (do not transfer to a pill organizer or unlabeled bag).
• Printed copy of the original prescription.
• Physician letter on letterhead listing medication, dose, indication, quantity, trip duration, and a U.S. contact number.
• For Japan: printed Yakkan Shoumei certificate applied for 14-30 days in advance^[9].
• For Australia (stays over 3 months): TGA personal-import permit^[11].
• Travel insurance with medical-evacuation coverage and a policy that explicitly covers prescription medication replacement.
• Insulated cooler bag (FRIO or equivalent) plus 2 frozen gel packs for the flight.
• $5 fridge thermometer for the hotel mini-bar check.
• Phone photo of the prescription label and the physician letter, stored in cloud storage as a backup.

Bottom line

• The TSA allows GLP-1 pens, syringes, and ice packs in carry-on without quantity restrictions^[1].
• Cabin temperature on commercial flights is inside the FDA room-temperature label range^[2][4]; a 6-12-hour flight needs no active cooling, longer flights benefit from a FRIO case plus a gel pack.
• Once-weekly dosing forgives time-zone shifts up to 4-5 days either direction; pick a new injection day for permanent relocations.
• Most countries permit a 90-day personal supply with original labeled packaging; Japan requires a Yakkan Shoumei certificate for larger quantities, applied for in advance^[9].
• Compounded-vial users need a physician letter, original prescription, compounding-pharmacy receipt, and sealed syringe packs to avoid customs escalation.
• Cruise medical centers do not stock GLP-1 medications; bring the full cruise supply plus one buffer pen.
• Replacement abroad is straightforward in EU / UK / Australia / Canada and difficult in Japan / Singapore / UAE; the buffer pen is the planning intervention.

Related research and tools

• How to travel with a GLP-1: the practical guide — the domestic-flight companion piece (TSA setup, cooler bag selection, time-zone basics)
• GLP-1 storage, shelf life, and refrigeration — the FDA-label storage windows by drug, including the room-temperature exposure clocks
• Wegovy pen vs compounded vial — practical differences — why the compounded user needs more travel documentation than the branded-pen user
• What happens when you stop semaglutide — the pharmacology of missed doses if a trip interruption forces a longer-than-label gap
• Wegovy drug page — the FDA-approved indication, dose ladder, and label storage section
• Ozempic drug page — the type-2-diabetes label (different indication, same molecule)
• Zepbound drug page — tirzepatide for chronic weight management, 21-day room- temperature storage window

Important disclaimer. This article is educational and does not constitute medical, legal, or customs advice. Customs rules change without notice; verify the destination country's current rules via its embassy or official customs site within 30 days of travel. The FDA-approved storage windows (Wegovy, Ozempic, Zepbound, Mounjaro) were taken from the DailyMed prescribing information for each drug and reflect the manufacturer's tested stability limits; do not exceed them. If a pen has frozen, been exposed above 86°F for any meaningful period, or looks discolored or cloudy, discard it and obtain a replacement — do not inject. Patients on a GLP-1 should not modify their dose schedule mid-trip without consulting their prescriber. Travel insurance with medical-evacuation and prescription-replacement coverage is strongly recommended for any trip longer than two weeks.

Last verified: 2026-05-28. Next review: every 12 months, or sooner if Japan, EU, UK, or Australia customs rules change for prescription injectables.